Business Wire

The Spanish Intellectual Property Register Recognises the Originality of the ENGAGE Templates

Share

The Spanish Intellectual Property Register has approved the registration of the ENGAGE Templates, confirming their status as an original and protected intellectual creation.

Developed by European DataWarehouse and Hypoport under the ENGAGE for ESG Activation Investments initiative, the Templates have now received formal recognition, reinforcing their uniqueness as a one-of-a-kind industry standard.

The registration not only recognises the originality of the ENGAGE Templates but also provides a secure foundation for their broader dissemination and use by formally establishing their protected status and validating their credibility as a trusted tool for regulatory compliance and ESG data harmonisation.

Marco Angheben, Coordinator of the ENGAGE for ESG initiative and Head of Business Development & Regulatory Affairs at European DataWarehouse, says: The registration of the ENGAGE Templates marks an important milestone for the initiative and clear recognition of the creative and technical work carried out by the teams at European DataWarehouse and Hypoport. We are now actively working with leading European lenders to establish ENGAGE as the go-to benchmark and invite the wider financial community to test the Templates through the ENGAGE Portal.

Jacco Samuels, Managing Director at Hypoport, adds:The complexities of sustainable finance reporting demand clarity and precision. The ENGAGE Templates represent a fundamental shift, born from two years of collaboration with the financial industry to meet these challenges. The ENGAGE Templates transform opaque requirements into actionable insights, providing a clear and efficient pathway to EU Taxonomy alignment for residential mortgages and renovations.”

The registration of the ENGAGE Templates marks a pivotal milestone for our consortium. It not only validates the originality and rigor of our work but also sets a new benchmark in sustainable finance reporting. As a group deeply committed to ESG principles, we see this as a transformative step that will significantly enhance transparency and comparability in the market. The ENGAGE Templates are more than a compliance tool—they are a strategic asset that will attract forward-looking investors seeking robust, standardised, and credible ESG disclosures. This achievement reinforces our leadership in sustainable innovation and our dedication to shaping a more resilient and responsible financial ecosystem,says Cátia Álves, Director of Corporate Sustainability at UCI Group and Director of Strategy and Innovation at UCI Brazil.

Martijn Breed, senior legal Counsel at Nationale-Nederlanden Bank and co-founder of the Woonnu mortgage label, comments: “The demand from investors for transparent ESG reporting on mortgage loan portfolios is growing. With the ENGAGE Templates we will be able to facilitate this for each investor for his own mortgage loan portfolio on a loan-by-loan basis. The ENGAGE Templates are easy to use and set a new standard for ESG reporting.”

The ENGAGE for ESG initiative, co-funded by the European Union, aims to establish a standardised and harmonised ESG disclosure framework for mortgages and renovation loans — helping simplify sustainability reporting.

The ENGAGE Templates provide a one-size-fits-all solution for lending institutions to meet the EU sustainability transparency requirements in a consistent and harmonised way. They can be applied across different financial instruments, including loan portfolios, specific funding structure, unsecured green bonds, as well as covered bond assets.

Each field in the ENGAGE Templates is aligned with the relevant section(s) of Annex I of the Climate Delegated Act, ensuring regulatory compatibility. Where data is not available, the Templates allow for “no data” options, promoting transparency and flexibility.

The ENGAGE Consortium conducts regular reviews of the ENGAGE taxonomy and data fields to ensure continuous improvement and finetune the requirements. The Templates have been operationalised through the ENGAGE Portal, a dedicated IT platform launched in March 2025.

The ENGAGE Templates are now accessible to lending institutions on request via the ENGAGE for ESG website. Further information is available at https://engage4esg.eurodw.eu/the-engage-templates/.

Project Background

Attracting private investments and stimulating green loan financing is crucial for the EU mission of achieving a zero-emission building stock by 2050. ENGAGE aims to provide a solution to have a single data disclosure format for mortgage funding and regulatory purposes encompassing the most relevant European ESG regulations such as the EU Taxonomy, EU GBS and EPBD. Thereby ENGAGE aims to facilitate a truly new format that facilitates both the banks, regulators and investors by combining existing mortgage disclosure(s) with new (and recently announced) ESG regulations, such as the EU Taxonomy. Creating transparency on definitions and requirements, with respect to the data-needs will allow the Financial Institutions to translate these needs towards the consumer products as well.

Why ENGAGE for ESG?

Buildings are responsible for approximately 40% of EU energy consumption and 36% of EU greenhouse gas emissions. Currently in Europe about 75% of existing buildings are qualified as ‘energy inefficient’; yet 85%-95% of today’s buildings will still be in use in 2050. Every year about 1% of buildings undergo an energy efficient renovation. Home renovations and the financing thereof should increase. Financing the energy efficiency improvement property stock is an important component in realising the greenhouse gas emission reduction objectives. The mortgage market can play a crucial role in providing funding to home renovation programmes aimed at improving the energy performance of the European building stock. The ENGAGE framework for energy efficient mortgages and renovations will create transparency through the translation and application of the relevant sections of the EU Taxonomy (and forthcoming EPBD) into the Dutch and Spanish national building and mortgage-lending practices that will ultimately contribute to standardisation of innovative and decarbonisation-targeted capital markets financing transactions.

DISCLAIMER: Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or CINEA. Neither the European Union nor the granting authority can be held responsible for them.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250519195670/en/

Contacts

Media Contact:
European DataWarehouse GmbH
Carla Scarsella
Tel. +49 (0) 69 50986 9320
Email: carla.scarsella@eurodw.eu

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 23:30:00 EEST | Press release

CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to existing therapies. Gilteritinib (Xospata®; Astellas Pharma, peak annual sales projection: $1.5 billion) and Quizartinib (Vanflyta®; Daiichi Sankyo) are two FDA-approved FLT3 inhibitors, with the former approved only for relapsed/refractory AML and the latter approved o

IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 23:05:00 EEST | Press release

IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global freight industry. “Einride shares our belief that quantum computing will fundamentally reshape and improve how large industries such as transportation and logistics operate,” said Niccolo de Masi, CEO of IonQ. “This partnership is aimed at creating a powerful platform with u

CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 22:26:00 EEST | Press release

CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current standard of care for EGFR-positive NSCLC is comprised of 3rd-generation inhibitors, most notably Osimertinib (Tagrisso®), whose annual sales exceed $6 billion. Most patients treated by tyrosine kinase inhibitors (TKIs) will eventually develop

NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 22:24:00 EEST | Press release

NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates

Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 22:08:00 EEST | Press release

As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye